185 related articles for article (PubMed ID: 12656541)
1. Erythropoietin therapy in children with bronchiolitis and anemia.
Jacobs BR; Lyons K; Brilli RJ
Pediatr Crit Care Med; 2003 Jan; 4(1):44-8. PubMed ID: 12656541
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin for critically ill children.
Lacroix J; Toledano B
Pediatr Crit Care Med; 2003 Jan; 4(1):123-4. PubMed ID: 12656562
[No Abstract] [Full Text] [Related]
3. Efficacy of recombinant human erythropoietin in critically ill patients admitted to a long-term acute care facility: a randomized, double-blind, placebo-controlled trial.
Silver M; Corwin MJ; Bazan A; Gettinger A; Enny C; Corwin HL
Crit Care Med; 2006 Sep; 34(9):2310-6. PubMed ID: 16878035
[TBL] [Abstract][Full Text] [Related]
4. [Erythropoietin treatment in critically ill children].
Chacón Aguilar R; Escorial Briso-Montiano M; Sopetrán Rey García M; García Sanz C; Rupérez Lucas M; López-Herce Cid J
An Pediatr (Barc); 2004 Nov; 61(5):398-402. PubMed ID: 15530318
[TBL] [Abstract][Full Text] [Related]
5. Anemia in the critically ill.
Shander A
Crit Care Clin; 2004 Apr; 20(2):159-78. PubMed ID: 15135458
[TBL] [Abstract][Full Text] [Related]
6. Blood conservation in the critically ill.
Thomas J; Martinez A
Am J Health Syst Pharm; 2007 Aug; 64(16 Suppl 11):S11-8. PubMed ID: 17687066
[TBL] [Abstract][Full Text] [Related]
7. A randomized, double-blind, placebo-controlled trial of recombinant erythropoietin in treatment of the anemia of bronchopulmonary dysplasia.
Ohls RK; Hunter DD; Christensen RD
J Pediatr; 1993 Dec; 123(6):996-1000. PubMed ID: 8229537
[TBL] [Abstract][Full Text] [Related]
8. Response of erythropoiesis and iron metabolism to recombinant human erythropoietin in intensive care unit patients.
van Iperen CE; Gaillard CA; Kraaijenhagen RJ; Braam BG; Marx JJ; van de Wiel A
Crit Care Med; 2000 Aug; 28(8):2773-8. PubMed ID: 10966249
[TBL] [Abstract][Full Text] [Related]
9. Important role of nondiagnostic blood loss and blunted erythropoietic response in the anemia of medical intensive care patients.
von Ahsen N; Müller C; Serke S; Frei U; Eckardt KU
Crit Care Med; 1999 Dec; 27(12):2630-9. PubMed ID: 10628602
[TBL] [Abstract][Full Text] [Related]
10. Efficacy of recombinant human erythropoietin in the critically ill patient: a randomized, double-blind, placebo-controlled trial.
Corwin HL; Gettinger A; Rodriguez RM; Pearl RG; Gubler KD; Enny C; Colton T; Corwin MJ
Crit Care Med; 1999 Nov; 27(11):2346-50. PubMed ID: 10579246
[TBL] [Abstract][Full Text] [Related]
11. Anemia in the critically ill: the role of erythropoietin.
Corwin HL
Semin Hematol; 2001 Jul; 38(3 Suppl 7):24-32. PubMed ID: 11523025
[TBL] [Abstract][Full Text] [Related]
12. Alternatives to blood product transfusion in the critically ill: erythropoietin.
Stubbs JR
Crit Care Med; 2006 May; 34(5 Suppl):S160-9. PubMed ID: 16617261
[TBL] [Abstract][Full Text] [Related]
13. Erythropoietin response to critical illness.
Krafte-Jacobs B; Levetown ML; Bray GL; Ruttimann UE; Pollack MM
Crit Care Med; 1994 May; 22(5):821-6. PubMed ID: 8181291
[TBL] [Abstract][Full Text] [Related]
14. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
15. Is there a place for epoetin alfa in managing anemia during critical illness?
Givens M; Lapointe M
Clin Ther; 2004 Jun; 26(6):819-29. PubMed ID: 15262453
[TBL] [Abstract][Full Text] [Related]
16. Recombinant human erythropoietin stimulates erythropoiesis and reduces erythrocyte transfusions in very low birth weight preterm infants.
Shannon KM; Keith JF; Mentzer WC; Ehrenkranz RA; Brown MS; Widness JA; Gleason CA; Bifano EM; Millard DD; Davis CB
Pediatrics; 1995 Jan; 95(1):1-8. PubMed ID: 7770284
[TBL] [Abstract][Full Text] [Related]
17. Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials.
Zarychanski R; Turgeon AF; McIntyre L; Fergusson DA
CMAJ; 2007 Sep; 177(7):725-34. PubMed ID: 17823140
[TBL] [Abstract][Full Text] [Related]
18. Early erythropoietin for preventing red blood cell transfusion in preterm and/or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2006 Jul; (3):CD004863. PubMed ID: 16856062
[TBL] [Abstract][Full Text] [Related]
19. Recombinant human erythropoietin in the treatment of the anemia of prematurity: results of a double-blind, placebo-controlled study.
Meyer MP; Meyer JH; Commerford A; Hann FM; Sive AA; Moller G; Jacobs P; Malan AF
Pediatrics; 1994 Jun; 93(6 Pt 1):918-23. PubMed ID: 8190577
[TBL] [Abstract][Full Text] [Related]
20. Comparison of a restricted transfusion schedule with erythropoietin therapy versus a restricted transfusion schedule alone in very low birth weight premature infants.
Birenbaum HJ; Pane MA; Helou SM; Starr KP
South Med J; 2006 Oct; 99(10):1059-62. PubMed ID: 17100024
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
